Whitehawk Therapeutics, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Morristown, NJ
WHWK chart
What traders are saying about $WHWK
Latest postsWhitehawk Therapeutics, Inc. news
- Whitehawk Therapeutics, Inc. Estimates – NASDAQ:WHWK
TradingView ·
- Whitehawk Therapeutics, Inc. Stock Price Prediction: Today, Tomorrow, Next Week (WHWK)
Traders Union ·
- Emerging Biotechs Standardize on Veeva Basics to Accelerate Drug Development
Yahoo Finance ·
- Whitehawk Therapeutics Presents Real-World Analyses Supporting MUC16 as a Durable ADC Target in Ovarian Cancer at IGCS 2026
Yahoo Finance ·
- Whitehawk Therapeutics Presents Real-World Analyses Supporting PTK7 as a Durable ADC Target in EGFR Wild-Type Non-Small Cell Lung Cancer at WCLC 2026
Yahoo Finance ·
- Whitehawk Therapeutics Appoints Vijay Iyengar, MD, to Board of Directors
Yahoo Finance ·
- Whitehawk Therapeutics to Participate in Upcoming Investor Conferences
Yahoo Finance ·
- What Makes Whitehawk Therapeutics, Inc. (WHWK) a Strong Momentum Stock: Buy Now?
Yahoo Finance ·
- Wall Street Analysts Predict a 47.64% Upside in Whitehawk Therapeutics, Inc. (WHWK): Here's What You Should Know
Yahoo Finance ·
- Akari Therapeutics Reports Second Quarter 2026 Financial Results and Highlights Progress of AKTX-101 Towards Phase 1 and Strategic Collaboration for Its ADC Payload Platform
Yahoo Finance ·
- Whitehawk Therapeutics Reports Second Quarter 2026 Financial Results and Recent Highlights
Yahoo Finance ·
- Akari Therapeutics CEO Explains Why Growing Industry Demand for Next-Generation ADC Payloads Positions the Company at the Center of a Major Oncology Opportunity
Yahoo Finance ·
Whitehawk Therapeutics, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $7.1M | $26.0M | $24.4M | $15.2M |
| Net income | -$20.6M | -$63.7M | -$65.8M | -$60.5M |
| Diluted EPS | $-0.33 | $-2.36 | $-2.44 | $-2.69 |
| Total assets (year end) | $150.8M | $70.3M | $132.4M | $184.2M |
| Cash and equivalents (year end) | $37.6M | $28.7M | $62.9M | $39.0M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Whitehawk Therapeutics, Inc.
- Ticker
- WHWK (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Morristown, NJ
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1422142
- Former names
- Aadi Bioscience, Inc., Aerpio Pharmaceuticals, Inc., ZETA ACQUISITION CORP II
Frequently asked questions
What exchange is Whitehawk Therapeutics, Inc. listed on?
Whitehawk Therapeutics, Inc. trades on the Nasdaq under the ticker symbol WHWK.
What industry is Whitehawk Therapeutics, Inc. in?
Whitehawk Therapeutics, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Whitehawk Therapeutics, Inc. headquartered?
Whitehawk Therapeutics, Inc.'s business address on file with the SEC is in Morristown, NJ.
When does Whitehawk Therapeutics, Inc.'s fiscal year end?
Whitehawk Therapeutics, Inc.'s fiscal year ends on December 31.
How much revenue did Whitehawk Therapeutics, Inc. report?
Whitehawk Therapeutics, Inc. reported $7.1M in revenue for calendar year 2025, according to its SEC filings.